Jake Paul vs. Anthony Joshua drug testing carried out by USADA, not VADA
The United States Anti-Doping Agency (USADA) has presided over the drug testing for the upcoming heavyweight bout between Anthony Joshua and Jake Paul, with both fighters having been tested “well over half a dozen times,” according to Joshua’s promoter, Eddie Hearn.
The event is being promoted by MVP – led by Paul and Nakisa Bidarian – meaning the drug-testing for the fights was at its discretion. For Paul’s last bout, a 10-round decision win over Julio Cesar Chavez Jnr, the highly respected Voluntary Anti-Doping Association (VADA) was responsible for testing the fighters.
“We didn't request no VADA testing [this time], we requested more intense testing with USADA, which is in place,” Bidarian told Boxing Scene.
Paul had been scheduled to take on Gervonta Davis until the lightweight ran into out-of-the-ring legal issues and on November 17, a little more than four weeks ago, Joshua was confirmed as a shock replacement.
“The most comprehensive program that the US Olympics use is USADA,” Bidarian continued. “When Jake [Paul] was going to fight Gervonta Davis, he put forward VADA. Gervonta [Davis] was very concerned, given he's a smaller man. His team wanted USADA, so we agreed to USADA. When we moved on to fight Anthony Joshua, we said, ‘Of course you want a drug test, but we're using USADA’.”
Hearn claims he and Joshua were happy to be tested by USADA, though he did stipulate that the decision to not use VADA – widely regarded as the leaders in the field – had nothing to do with them. “That was a decision from MVP,” Hearn said.
Asked whether they pushed for VADA testing, he added: “Yeah, but we've been VADA-tested our whole career. USADA are a very reputable agency as well.
“We didn't have a problem with it. USADA are extremely reputable, it's not like some random agency that's popped up from nowhere. But we were tested by UKAD as well. Well over half-a-dozen tests, I believe. So we were happy with the procedure.”